Skip to main content
Top
Published in: BMC Cancer 1/2008

Open Access 01-12-2008 | Research article

Competing risks to breast cancer mortality in Catalonia

Published in: BMC Cancer | Issue 1/2008

Login to get access

Abstract

Background

Breast cancer mortality has experienced important changes over the last century. Breast cancer occurs in the presence of other competing risks which can influence breast cancer incidence and mortality trends. The aim of the present work is: 1) to assess the impact of breast cancer deaths among mortality from all causes in Catalonia (Spain), by age and birth cohort and 2) to estimate the risk of death from other causes than breast cancer, one of the inputs needed to model breast cancer mortality reduction due to screening or therapeutic interventions.

Methods

The multi-decrement life table methodology was used. First, all-cause mortality probabilities were obtained by age and cohort. Then mortality probability for breast cancer was subtracted from the all-cause mortality probabilities to obtain cohort life tables for causes other than breast cancer. These life tables, on one hand, provide an estimate of the risk of dying from competing risks, and on the other hand, permit to assess the impact of breast cancer deaths on all-cause mortality using the ratio of the probability of death for causes other than breast cancer by the all-cause probability of death.

Results

There was an increasing impact of breast cancer on mortality in the first part of the 20th century, with a peak for cohorts born in 1945–54 in the 40–49 age groups (for which approximately 24% of mortality was due to breast cancer). Even though for cohorts born after 1955 there was only information for women under 50, it is also important to note that the impact of breast cancer on all-cause mortality decreased for those cohorts.

Conclusion

We have quantified the effect of removing breast cancer mortality in different age groups and birth cohorts. Our results are consistent with US findings. We also have obtained an estimate of the risk of dying from competing-causes mortality, which will be used in the assessment of the effect of mammography screening on breast cancer mortality in Catalonia.
Appendix
Available only for authorised users
Literature
2.
go back to reference Rosenberg MA: Competing risks to breast cancer mortality. J Natl Cancer Inst Monogr. 2006, 15-19. 36 Rosenberg MA: Competing risks to breast cancer mortality. J Natl Cancer Inst Monogr. 2006, 15-19. 36
3.
go back to reference Habbema JD, Schechter CB, Cronin KA, Clarke LD, Feuer EJ: Modeling cancer natural history, epidemiology, and control: reflections on the CISNET breast group experience. J Natl Cancer Inst Monogr. 2006, 122-126. 36 Habbema JD, Schechter CB, Cronin KA, Clarke LD, Feuer EJ: Modeling cancer natural history, epidemiology, and control: reflections on the CISNET breast group experience. J Natl Cancer Inst Monogr. 2006, 122-126. 36
4.
go back to reference Lee S, Zelen M: A stochastic model for predicting the mortality of breast cancer. J Natl Cancer Inst Monogr. 2006, 79-86. 36 Lee S, Zelen M: A stochastic model for predicting the mortality of breast cancer. J Natl Cancer Inst Monogr. 2006, 79-86. 36
5.
go back to reference Masuet C, Seculi E, Brugulat P, Tresserras R: The practice of preventive mammography in Catalonia [Spain]: a step forward. Gac Sanit. 2004, 18 (4): 321-325.CrossRefPubMed Masuet C, Seculi E, Brugulat P, Tresserras R: The practice of preventive mammography in Catalonia [Spain]: a step forward. Gac Sanit. 2004, 18 (4): 321-325.CrossRefPubMed
8.
go back to reference S Shryock H, Siegel JS, Associates: The Methods and Materials of Demography (Studies in Population). 1976, San Diego: Academic Press S Shryock H, Siegel JS, Associates: The Methods and Materials of Demography (Studies in Population). 1976, San Diego: Academic Press
11.
go back to reference Elandt-Johnson RC, Johnson NL: Survival Models and Data Analysis. 1980, John Wiley & Sons edn. New York: John Wiley & Son Elandt-Johnson RC, Johnson NL: Survival Models and Data Analysis. 1980, John Wiley & Sons edn. New York: John Wiley & Son
12.
13.
go back to reference Kelsey JL, Gammon MD: The epidemiology of breast cancer. CA Cancer J Clin. 1991, 41 (3): 146-165. 10.3322/canjclin.41.3.146.CrossRefPubMed Kelsey JL, Gammon MD: The epidemiology of breast cancer. CA Cancer J Clin. 1991, 41 (3): 146-165. 10.3322/canjclin.41.3.146.CrossRefPubMed
15.
go back to reference Borràs JMBJ, Bosch FX, Fernández E, Galceran J, Gispert R, González JR, Izquierdo A, Marcos R, Moreno V, Peris M, Puig X, Sánchez V, Viladiu P: Càncer Catalunya 2001. 2001, L'Hospitalet: Institut Català d'Oncologia, Departament de Sanitat i Seguretat Social Borràs JMBJ, Bosch FX, Fernández E, Galceran J, Gispert R, González JR, Izquierdo A, Marcos R, Moreno V, Peris M, Puig X, Sánchez V, Viladiu P: Càncer Catalunya 2001. 2001, L'Hospitalet: Institut Català d'Oncologia, Departament de Sanitat i Seguretat Social
16.
go back to reference Puig X, Ginebra J, Gispert R: Analysis of mortality time trend using generalized linear models. Gac Sanit. 2005, 19 (6): 481-485.CrossRefPubMed Puig X, Ginebra J, Gispert R: Analysis of mortality time trend using generalized linear models. Gac Sanit. 2005, 19 (6): 481-485.CrossRefPubMed
18.
go back to reference Cronin KA, Feuer EJ, Clarke LD, Plevritis SK: Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the cisnet breast cancer base case analysis. J Natl Cancer Inst Monogr. 2006, 112-121. 36 Cronin KA, Feuer EJ, Clarke LD, Plevritis SK: Impact of adjuvant therapy and mammography on U.S. mortality from 1975 to 2000: comparison of mortality results from the cisnet breast cancer base case analysis. J Natl Cancer Inst Monogr. 2006, 112-121. 36
19.
go back to reference Parkin DM, Whelan SL, Ferlay J, Storm H: Cancer Incidence in Five Continents, Vol. I to VIII. IARC CancerBase No 7, Lyon. 2005, IARC CancerBase No. 7, Lyon Parkin DM, Whelan SL, Ferlay J, Storm H: Cancer Incidence in Five Continents, Vol. I to VIII. IARC CancerBase No 7, Lyon. 2005, IARC CancerBase No. 7, Lyon
21.
go back to reference Botha JL, Bray F, Sankila R, Parkin DM: Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer. 2003, 39 (12): 1718-1729. 10.1016/S0959-8049(03)00118-7.CrossRefPubMed Botha JL, Bray F, Sankila R, Parkin DM: Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer. 2003, 39 (12): 1718-1729. 10.1016/S0959-8049(03)00118-7.CrossRefPubMed
22.
go back to reference Fine J, Gray R: A Proportional Hazards Model for the Subdistribution of a Competing Risk. J Am Statist Ass. 1999, 94 (446): 496-509. 10.2307/2670170.CrossRef Fine J, Gray R: A Proportional Hazards Model for the Subdistribution of a Competing Risk. J Am Statist Ass. 1999, 94 (446): 496-509. 10.2307/2670170.CrossRef
23.
go back to reference Schairer C, Mink PJ, Carroll L, Devesa SS: Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst. 2004, 96 (17): 1311-1321.CrossRefPubMed Schairer C, Mink PJ, Carroll L, Devesa SS: Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst. 2004, 96 (17): 1311-1321.CrossRefPubMed
24.
go back to reference Chiang CL: Competing risks in mortality analysis. Annu Rev Public Health. 1991, 12: 281-307. 10.1146/annurev.pu.12.050191.001433.CrossRefPubMed Chiang CL: Competing risks in mortality analysis. Annu Rev Public Health. 1991, 12: 281-307. 10.1146/annurev.pu.12.050191.001433.CrossRefPubMed
25.
go back to reference Perez-Gomez B, Aragones N, Pollan M, Suarez B, Lope V, Llacer A, Lopez-Abente G: Accuracy of cancer death certificates in Spain: a summary of available information. Gac Sanit. 2006, 20 (Suppl 3): 42-51. 10.1157/13101089.CrossRefPubMed Perez-Gomez B, Aragones N, Pollan M, Suarez B, Lope V, Llacer A, Lopez-Abente G: Accuracy of cancer death certificates in Spain: a summary of available information. Gac Sanit. 2006, 20 (Suppl 3): 42-51. 10.1157/13101089.CrossRefPubMed
26.
go back to reference de Aran Bares M, Perez G, Rosell J, Molina P: Exactness of mortality statistics by external and natural causes of death with medico-legal intervention in Catalonia, 1996. Gac Sanit. 2000, 14 (5): 356-362.CrossRefPubMed de Aran Bares M, Perez G, Rosell J, Molina P: Exactness of mortality statistics by external and natural causes of death with medico-legal intervention in Catalonia, 1996. Gac Sanit. 2000, 14 (5): 356-362.CrossRefPubMed
Metadata
Title
Competing risks to breast cancer mortality in Catalonia
Publication date
01-12-2008
Published in
BMC Cancer / Issue 1/2008
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-8-331

Other articles of this Issue 1/2008

BMC Cancer 1/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine